{ "items": [ "\n\n
Petrou S. et al, (2015), Pharmacoeconomics, 33, 985 - 991
\n \n \n \n\n \n
\n \n \nPetrou S. et al, (2015), Medical Decision Making, 35, Np1 - Np8
\n \n \n \n\n \n
\n \n \nPetrou S. et al, (2015), J Med Econ, 18, 851 - 857
\n \n \n \n\n \n
\n \n \nPetrou S. et al, (2015), Value in Health, 18, A715 - A716
\n \n \n \n\n \n
\n \n \nPetrou S. et al, (2015), Pharmacoeconomics, 33, 993 - 1011
\n \n \n \n\n \n
\n \n \nDakin HA. et al, (2014), BMJ Open, 4
\n \n \n \n\n \n
\n \n \nMurray DW. et al, (2014), Health Technol Assess, 18, 1 - viii
\n \n \n \n\n \n
\n \n \nChakravarthy U. et al, (2013), Lancet, 382, 1258 - 1267
\n \n \n \n\n \n
\n \n \nDakin H., (2013), Health Qual Life Outcomes, 11
\n \n \n \n\n \n
\n \n \nRamos-Go\u00f1ni JM. et al, (2013), Stata Journal, 13, 474 - 491
\n \n \n \n\n \n
\n \n \nRogers C. et al, (2013), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 54
\n \n \n \n\n \n
\n \n \nBreeman S. et al, (2013), Bone Joint J, 95-B, 486 - 492
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2013), Qual Life Res, 22, 683 - 694
\n \n \n \n\n \n
\n \n \nDakin H. and Wordsworth S., (2013), Health Economics (United Kingdom), 22, 22 - 34
\n \n \n \n\n \n
\n \n \nDakin H. and Wordsworth S., (2013), Health Econ, 22, 22 - 34
\n \n \n \n\n \n
\n \n \nChakravarthy U. et al, (2012), Ophthalmology, 119, 1399 - 1411
\n \n \n \n\n \n
\n \n \nGray A. et al, (2012), Joint meeting of the Health Economists' Study Group and the Coll\u00e8ge des \u00e9conomistes de la sant\u00e9 Aix-en-Provence, France, 11-13 January 2012
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2012), Quality of Life Research, 1 - 12
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2012), BMJ Open, 2
\n \n \n \n\n \n
\n \n \nChoy E. et al, (2011), Semin Arthritis Rheum, 41, 335 - 45.e6
\n \n \n \n\n \n
\n \n \n